Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,512 | -15,095 | -51,418 | -37,783 | -23,694 |
| Depreciation Amortization | -177 | -85 | -239 | -151 | -88 |
| Other Working Capital | 111 | -4,628 | 5,371 | 2,595 | -156 |
| Other Operating Activity | 1,973 | 962 | 4,189 | 3,304 | 2,183 |
| Operating Cash Flow | $-32,605 | $-18,846 | $-42,097 | $-32,035 | $-21,755 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -757 | -723 | -12,957 | -13,572 | -13,150 |
| PPE Investments | -125 | -65 | -191 | -103 | -103 |
| Investing Cash Flow | $-882 | $-788 | $-13,148 | $-13,675 | $-13,253 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,020 | 1,020 | N/A | N/A | N/A |
| Debt Repayment | -364 | -90 | N/A | N/A | N/A |
| Common Stock Issued | 28,486 | 558 | 3,210 | 1,259 | 88 |
| Financing Cash Flow | $29,142 | $1,488 | $3,210 | $1,259 | $88 |
| Beginning Cash Position | 67,131 | 67,131 | 119,166 | 119,166 | 119,166 |
| End Cash Position | 62,786 | 48,985 | 67,131 | 74,715 | 84,246 |
| Net Cash Flow | $-4,345 | $-18,146 | $-52,035 | $-44,451 | $-34,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,605 | -18,846 | -42,097 | -32,035 | -21,755 |
| Capital Expenditure | -125 | -65 | -191 | -103 | -103 |
| Free Cash Flow | -32,730 | -18,911 | -42,288 | -32,138 | -21,858 |